---
figid: PMC3093868__zbc0201157820009
figlink: /pmc/articles/PMC3093868/figure/F9/
number: F9
caption: Schematic presentation of BAD serine 134 phosphorylation in RAF and RAS mutant
  tumor cells. Stimulation of receptor tyrosine kinase (TRK) at the plasma membrane
  (PM) leads to activation of RAS GTPases and RAF kinases. The cell lines HCT 116,
  DX3, and MEL-Juso carry mutated RAS genes, resulting in enhanced activation of the
  PI3K/Akt pathway. Although Akt was shown to be a BAD-targeting kinase, it has a
  minor contribution in phosphorylating BAD at serine 134. The cell lines A375 and
  SK-MEL-28 harbor an activating mutation within B-RAF (V600E) that leads to elevated
  phosphorylation of BAD serine 134, mainly through the MEK-ERK cascade. The specific
  inhibitors of RAF, MEK, and PI3K are highlighted in blue boxes. Phosphorylation
  of BAD at serine 134 affects the efficiency of apoptosis and proliferation. Thick
  arrows indicate enhanced activation or phosphorylation. For more details, see “Results”
  and “Discussion” sections.
pmcid: PMC3093868
papertitle: BAD Contributes to RAF-mediated Proliferation and Cooperates with B-RAF-V600E
  in Cancer Signaling.
reftext: Lisa Polzien, et al. J Biol Chem. 2011 May 20;286(20):17934-17944.
pmc_ranked_result_index: '84034'
pathway_score: 0.9596552
filename: zbc0201157820009.jpg
figtitle: Schematic presentation of BAD serine 134 phosphorylation in RAF and RAS
  mutant tumor cells
year: '2011'
organisms:
- Homo sapiens
ndex: 68b35350-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3093868__zbc0201157820009.html
  '@type': Dataset
  description: Schematic presentation of BAD serine 134 phosphorylation in RAF and
    RAS mutant tumor cells. Stimulation of receptor tyrosine kinase (TRK) at the plasma
    membrane (PM) leads to activation of RAS GTPases and RAF kinases. The cell lines
    HCT 116, DX3, and MEL-Juso carry mutated RAS genes, resulting in enhanced activation
    of the PI3K/Akt pathway. Although Akt was shown to be a BAD-targeting kinase,
    it has a minor contribution in phosphorylating BAD at serine 134. The cell lines
    A375 and SK-MEL-28 harbor an activating mutation within B-RAF (V600E) that leads
    to elevated phosphorylation of BAD serine 134, mainly through the MEK-ERK cascade.
    The specific inhibitors of RAF, MEK, and PI3K are highlighted in blue boxes. Phosphorylation
    of BAD at serine 134 affects the efficiency of apoptosis and proliferation. Thick
    arrows indicate enhanced activation or phosphorylation. For more details, see
    “Results” and “Discussion” sections.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SHC1
  - SOS1
  - MAPK3
  - SOS2
  - BAD
  - MAPK1
  - SHC4
  - AKT2
  - SHC2
  - SHC3
  - GRB2
  - RAF1
  - MAP2K1
  - PIK3CG
  - ARAF
  - AKT1
  - AKT3
  - MAP2K2
  - PIK3R3
  - PIK3CA
  - NRAS
  - PIK3R6
  - PIK3R5
  - PIK3CB
  - PIK3R4
  - KRAS
  - BRAF
  - HRAS
  - PIK3CD
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: Shc
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3093868__F9
redirect_from: /figures/PMC3093868__F9
figtype: Figure
---
